Transocean announces $5.8B all-stock acquisition of Valaris, combining 73 offshore drilling rigs to create industry leader with $17B enterprise value. Deal expected to close in H2 2026.
Kyndryl slashes revenue forecast and reports leadership changes as SEC reviews cash management practices. Shares drop 40% on internal control concerns.
Eli Lilly acquires Orna Therapeutics to advance groundbreaking in vivo CAR-T therapies for autoimmune diseases using circular RNA technology.
DA Davidson upgrades Oracle to Buy, citing strong OpenAI outlook and reduced risks, with a $180 price target.
Morgan Stanley gives Overweight ratings to TeraWulf and Cipher Mining, highlighting strong infrastructure experience and upside potential in bitcoin-to-data center conversions.
Wells Fargo upgrades GeneDx to Overweight, saying the recent stock decline looks excessive and growth opportunities could drive momentum into 2026.
